Minima Stent System Post- Approval Study (PAS)

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

May 21, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

December 31, 2031

Conditions
Pulmonary Artery StenosisAortic Coarctation
Interventions
DEVICE

Minima Stent System

Minima Stent System is indicated for use in the treatment of native or acquired pulmonary artery stenoses or coarctation of the aorta in neonates, infants, and children at least 1.5kg in weight.

Trial Locations (15)

15224

RECRUITING

UPMC Children's Hospital of Pittsburgh, Pittsburgh

22903

RECRUITING

UVA Health Children's Hospital, Charlottesville

30329

RECRUITING

Children's Healthcare of Atlanta, Atlanta

33155

RECRUITING

Nicklaus Children's Hospital, Miami

43205

RECRUITING

Nationwide Children's Hospital, Columbus

45229

RECRUITING

Cincinnati Children's Hospital Medical Center, Cincinnati

46202

RECRUITING

Riley Hospital for Children at Indiana University Health, Indianapolis

60611

RECRUITING

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

63130

RECRUITING

Washington University, Saint Louis

75230

RECRUITING

Columbia Hospital at Medical City Dallas Hospital, Dallas

78723

RECRUITING

Dell Children's Medical Center, The University of Texas at Austin, Austin

80045

RECRUITING

Children's Hospital Colorado, Aurora

90027

RECRUITING

Children's Hospital Los Angeles, Los Angeles

98105

RECRUITING

Seattle Children's Hospital, Seattle

02115

RECRUITING

Boston Children's Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Renata Medical

INDUSTRY

NCT06828770 - Minima Stent System Post- Approval Study (PAS) | Biotech Hunter | Biotech Hunter